| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | 694 | 23 | 1.243 | 580 | 1.084 | 1.111 | 1.163 | 1.160 | 1.216 | 1.303 |
| Gross Profit/Loss - EUR | -694 | -23 | -1.243 | -580 | -1.084 | -1.111 | -1.163 | -1.160 | -1.216 | -1.303 |
| Net Profit/Loss - EUR | -694 | -23 | -1.243 | -580 | -1.084 | -1.111 | -1.163 | -1.160 | -1.216 | -1.303 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - International Pharmaceutical Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 51.944 | 51.414 | 50.544 | 49.617 | 48.656 | 47.733 | 46.675 | 46.820 | 46.678 | 46.417 |
| Current Assets | 41.802 | 41.352 | 39.409 | 38.106 | 36.284 | 34.486 | 32.558 | 31.499 | 30.232 | 30.063 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 33.643 | 33.300 | 32.736 | 32.136 | 31.513 | 30.916 | 30.230 | 30.324 | 30.232 | 30.063 |
| Cash | 8.159 | 8.052 | 6.673 | 5.971 | 4.771 | 3.570 | 2.328 | 1.175 | 0 | 0 |
| Shareholders Funds | 32.347 | 31.994 | 30.209 | 29.075 | 27.428 | 25.797 | 24.062 | 22.977 | 21.691 | 20.267 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 61.399 | 60.773 | 59.744 | 58.648 | 57.512 | 56.422 | 55.171 | 55.342 | 55.218 | 56.213 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6810 - 6810" | |||||||||
| CAEN Financial Year |
6810
|
|||||||||
Comments - International Pharmaceutical Srl